article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

The Changing Landscape of Pharmacy Accessibility

Pharmacy Times

Mail-order pharmacies can offer cost savings depending on insurance coverage and are well suited for filling medications for chronic conditions, as they offer 90-day supplies and automatic refills. This can expand access to underserved communities and improve patient outcomes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Lifesaving Role of Continuous Glucose Monitors and Wearable Devices

Pharmacy Times

The most common concerns include the following 1,3-5 : • Cost and insurance barriers: Affordability remains a major barrier, as patients have difficulty accessing CGMs due to high out-of-pocket costs or limited insurance coverage.

article thumbnail

A Review of Oral Cephalosporins for Common Outpatient Infections

Pharmacy Times

Additional considerations for selection between oral cephalosporin agents include differences in bioavailability and absorption, specific site of infection and the ability of drug to concentrate at that site, local resistance patterns, insurance coverage, available formulations, and cost to the patient.

article thumbnail

How AI Brings Pharmacogenetics to the Frontline of Precision Medicine

Pharmacy Times

4 Though the US still stops short of requiring testing outright, this marks a critical turning point—shifting responsibility onto clinicians and paving the way for broader insurance coverage and adoption. Real-World Evidence, Emerging Therapies, and Demonstrating Value Technological advances are accelerating this progress.

article thumbnail

ADA 2025: Ready-to-Use Glucagon Empowers Diabetes Patient Safety

Pharmacy Times

Goldman and Isaacs emphasize the importance of identifying at-risk patients through various health care touchpoints, including doctor's offices and pharmacies, and advocate for routine glucagon prescription and insurance coverage.

article thumbnail

ADA 2025: Breaking Barriers in Glucagon Prescription

Pharmacy Times

They highlighted that only 4% of the 15 million people using insulin have a glucagon prescription, largely due to misconceptions about ease of use, cost, and insurance coverage. Goldman and Isaacs discussed the significant barriers to glucagon prescription and utilization for individuals with diabetes.